Phenotypic and genotypic characterization of influenza virus mutants selected with the sialidase fusion protein DAS181
Open Access
- 21 November 2010
- journal article
- research article
- Published by Oxford University Press (OUP) in Journal of Antimicrobial Chemotherapy
- Vol. 66 (1), 15-28
- https://doi.org/10.1093/jac/dkq387
Abstract
Influenza viruses (IFVs) frequently achieve resistance to antiviral drugs, necessitating the development of compounds with novel mechanisms of action. DAS181 (Fludase®), a sialidase fusion protein, may have a reduced potential for generating drug resistance due to its novel host-targeting mechanism of action. IFV strains B/Maryland/1/59 and A/Victoria/3/75 (H3N2) were subjected to >30 passages under increasing selective pressure with DAS181. The DAS181-selected IFV isolates were characterized in vitro and in mice. Despite extensive passaging, DAS181-selected viruses exhibited a very low level of resistance to DAS181, which ranged between 3- and 18-fold increase in EC50. DAS181-selected viruses displayed an attenuated phenotype in vitro, as exhibited by slower growth, smaller plaque size and increased particle to pfu ratios relative to wild-type virus. Further, the DAS181 resistance phenotype was unstable and was substantially reversed over time upon DAS181 withdrawal. In mice, the DAS181-selected viruses exhibited no greater virulence than their wild-type counterparts. Genotypic and phenotypic analysis of DAS181-selected viruses revealed mutations in the haemagglutinin (HA) and neuraminidase (NA) molecules and also changes in HA and NA function. Results indicate that resistance to DAS181 is minimal and unstable. The DAS181-selected IFV isolates exhibit reduced fitness invitro, likely due to altered HA and NA functions.This publication has 54 references indexed in Scilit:
- DAS181, a sialidase fusion protein, protects human airway epithelium against influenza virus infection: an in vitro pharmacodynamic analysisJournal of Antimicrobial Chemotherapy, 2009
- DAS181 Inhibits H5N1 Influenza Virus Infection of Human Lung TissuesAntimicrobial Agents and Chemotherapy, 2009
- Recent Avian H5N1 Viruses Exhibit Increased Propensity for Acquiring Human Receptor SpecificityJournal of Molecular Biology, 2008
- Surveillance for Neuraminidase Inhibitor Resistance among Human Influenza A and B Viruses Circulating Worldwide from 2004 to 2008Antimicrobial Agents and Chemotherapy, 2008
- Contemporary North American influenza H7 viruses possess human receptor specificity: Implications for virus transmissibilityProceedings of the National Academy of Sciences of the United States of America, 2008
- Structural basis for receptor specificity of influenza B virus hemagglutininProceedings of the National Academy of Sciences of the United States of America, 2007
- Receptor binding specificity of recent human H3N2 influenza virusesVirology Journal, 2007
- Haemagglutinin mutations responsible for the binding of H5N1 influenza A viruses to human-type receptorsNature, 2006
- Sialidase Fusion Protein as a Novel Broad-Spectrum Inhibitor of Influenza Virus InfectionAntimicrobial Agents and Chemotherapy, 2006
- Universal primer set for the full-length amplification of all influenza A virusesArchiv für die gesamte Virusforschung, 2001